SBD   /     N208 - Antidiabéticos orais no paciente internado - Emerson Cestari Marino

Description

Autor: Emerson Cestari Marino Revista: Lancet Diabetes Endocrinol, Nat Med Ref: 1) Pasquel FJ. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021 Mar;9(3):174-188. 2) Kosiborod MN. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2021 Sep;9(9):586-594. 3) Voors AA. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. Nat Med. 2022 Mar;28(3):568-574.

Subtitle
Autor: Emerson Cestari Marino Revista: Lancet Dia…
Duration
00:08:04
Publishing date
2022-06-14 18:04
Link
https://soundcloud.com/diabetes_sbd/n208-antidiabeticos-orais-no-paciente-internado-emerson-cestari-marino
Contributors
  SBD
author  
Enclosures
https://feeds.soundcloud.com/stream/1287454453-diabetes_sbd-n208-antidiabeticos-orais-no-paciente-internado-emerson-cestari-marino.mp3
audio/mpeg